Allergan Aesthetics Announces BOTOX® Cosmetic Day for November 18
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced two initiatives at the 2026 American Society for Dermatologic Surgery (ASDS) Annual Meeting: the presentation of nine new research abstracts and the return of BOTOX® Cosmetic Day on Wednesday, November 18, 2026.
Among the research being presented are findings on aesthetic care for patients who have undergone medical weight loss, a growing patient group reshaping the aesthetics industry. The studies include data on patient satisfaction with facial appearance and psychosocial well-being after treatment with hyaluronic acid injectables.
Allergan is also drawing on insights from its landmark “What Consumers Really Want” report, which examines changing consumer expectations and common misconceptions about aesthetic treatments. As GLP-1 weight-loss medications continue to grow in popularity, dermatologists and aesthetic practitioners are seeing more patients seeking skin-tightening and facial-volumizing treatments.
BOTOX® Cosmetic Day is an annual consumer event that encourages people to explore FDA-approved cosmetic treatments with certified providers nationwide.
Source: PR Newswire – November 3, 2026